Amalgamated Bank Trims Position in Chemed Co. (NYSE:CHE)

Amalgamated Bank lessened its stake in shares of Chemed Co. (NYSE:CHE) by 7.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,676 shares of the company’s stock after selling 640 shares during the quarter. Amalgamated Bank’s holdings in Chemed were worth $4,165,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. William Blair Investment Management LLC grew its holdings in Chemed by 2.7% during the 2nd quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock valued at $257,927,000 after buying an additional 12,705 shares in the last quarter. Impax Asset Management Group plc grew its holdings in shares of Chemed by 19.5% during the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after purchasing an additional 51,974 shares in the last quarter. TD Asset Management Inc grew its holdings in shares of Chemed by 10.9% during the second quarter. TD Asset Management Inc now owns 282,753 shares of the company’s stock worth $153,416,000 after purchasing an additional 27,800 shares in the last quarter. Boston Trust Walden Corp grew its holdings in shares of Chemed by 5.2% during the second quarter. Boston Trust Walden Corp now owns 221,440 shares of the company’s stock worth $120,149,000 after purchasing an additional 11,036 shares in the last quarter. Finally, Epoch Investment Partners Inc. grew its holdings in shares of Chemed by 20.1% during the first quarter. Epoch Investment Partners Inc. now owns 182,776 shares of the company’s stock worth $117,329,000 after purchasing an additional 30,614 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 0.5 %

Shares of NYSE CHE opened at $582.06 on Friday. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The firm has a market capitalization of $8.81 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.31 and a beta of 0.44. The business has a 50-day moving average of $569.34 and a 200-day moving average of $577.64.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. During the same period in the previous year, the firm posted $4.71 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, analysts predict that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a $0.50 dividend. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed’s payout ratio is presently 10.76%.

Insider Buying and Selling

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Chemed news, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares in the company, valued at $1,991,615.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. The disclosure for this sale can be found here. Insiders sold 6,744 shares of company stock worth $3,828,231 in the last quarter. 3.32% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.